Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)
Hong Kong · Delayed Price · Currency is HKD 5.21
+0.03 (0.58%)
Jan 21, 2026, 3:15 PM HKT
HKG:1066 Market Cap
HKG:1066 has a market cap or net worth of 23.48 billion as of January 20, 2026. Its market cap has increased by 12.91% in one year.
Market Cap
23.48B
Enterprise Value
20.69B
Revenue
14.35B
Ranking
n/a
PE Ratio
10.99
Stock Price
5.21
Market Cap Chart
Since February 27, 2004, HKG:1066's market cap has increased from 572.70M to 23.48B, an increase of 4,000.23%. That is a compound annual growth rate of 18.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 23.48B | 3.04% |
| Dec 31, 2025 | 22.79B | 8.39% |
| Dec 31, 2024 | 21.02B | -39.55% |
| Dec 29, 2023 | 34.78B | -40.64% |
| Dec 30, 2022 | 58.60B | 33.16% |
| Dec 31, 2021 | 44.00B | -44.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 291.88B |
| Hansoh Pharmaceutical Group Company | 260.32B |
| JD Health International | 212.13B |
| WuXi Biologics | 156.50B |
| Innovent Biologics | 148.05B |
| Sino Biopharmaceutical | 124.24B |
| CSPC Pharmaceutical Group | 112.39B |
| Sichuan Kelun-Biotech Biopharmaceutical | 110.48B |